Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Country / region: Italy Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20131
20152
20183
20191
20213
20222
20232
20241
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting8
Active, not recruiting6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
European Organisation for Research and Treatment of Cancer - EORTC3
AstraZeneca2
Karyopharm Therapeutics Inc2
AEterna Zentaris1
ARCAGY/ GINECO GROUP1
Advenchen Laboratories, LLC1
BioNTech SE1
Catholic University of the Sacred Heart1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms26
Uterine Neoplasms4
Neoplasms3
Neoplasm Metastasis2
Ovarian Neoplasms2
Sarcoma2
Sarcoma, Endometrial Stromal2
Uterine Cervical Neoplasms2
Fallopian Tube Neoplasms1
Fibrosarcoma1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.